D. VICTOR PERLROTH, M.D. 13D and 13G filings for Kodiak Sciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:02 pm Purchase |
2024-12-31 | 13G | Kodiak Sciences Inc. KOD |
D. VICTOR PERLROTH, M.D. | 6,164,427 11.000% |
406,000 (+7.05%) |
Filing |
| 2024-02-14 4:23 pm Sale |
2023-12-31 | 13G | Kodiak Sciences Inc. KOD |
D. VICTOR PERLROTH, M.D. | 5,758,427 10.400% |
-932,894 (-13.94%) |
Filing |
| 2023-02-14 4:19 pm Purchase |
2022-12-31 | 13G | Kodiak Sciences Inc. KOD |
D. VICTOR PERLROTH, M.D. | 6,691,321 12.200% |
433,158 (+6.92%) |
Filing |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Kodiak Sciences Inc. KOD |
D. VICTOR PERLROTH, M.D. | 6,258,163 11.600% |
277,258 (+4.64%) |
Filing |
| 2021-02-16 5:09 pm Purchase |
2020-12-31 | 13G | Kodiak Sciences Inc. KOD |
D. VICTOR PERLROTH, M.D. | 5,980,905 11.400% |
342,157 (+6.07%) |
Filing |